Protease inhibitors and penetration enhancers as approaches to modify peptide absorption

Journal of Controlled Release

Volumn 13, Issue 2-3, 1990, Pages 213-223

  Lee, Vincent H L ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

paracellular pathway; penetration enhancers; peptidase inhibitors; peptide delivery systems; transmucosal peptide absorption

Indexed keywords

1,10 PHENANTHROLINE; APROTININ; ARGIPRESSIN; BACITRACIN; BESTATIN; BUSERELIN; CALCITONIN; DRUG; DYFLOS; GLYCOCHOLIC ACID; GONADORELIN; HYDROXYMERCURIBENZOIC ACID; INSULIN; PEPTIDE; PHOSPHORAMIDON; PROTEIN; PROTEINASE INHIBITOR; PUROMYCIN; SOYBEAN TRYPSIN INHIBITOR;

CONFERENCE PAPER; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG PENETRATION; HUMAN; INTRANASAL DRUG ADMINISTRATION; INTRAVAGINAL DRUG ADMINISTRATION; METHODOLOGY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RECTAL DRUG ADMINISTRATION;

EID: 0025113804     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-3659(90)90011-H     Document Type: Article

References (113)

1. Vaginal absorption of a potent luteinizing hormone-releasing hormone analog (leuprolide) in rats. I. Absorption by various routes and absorption enhancement
2. Vaginal absorption of a potent luteinizing hormonereleasing hormone analogue (leuprolide) in rats. II. Mechanism of absorption enhancement with organic acids
3. Intestinal absorption of insulin in the rat
4. A study on the mode of administration of thyrotropin releasing hormone (TRH) in mice
5. Absorption kinetics of subcutaneously injected insulin. Evidence for degradation at injection site
6. 125I-insulin absorption and blood glucose concentration
7. Accelerated insulin degradation: an alternative mechanism for insulin resistance
8. Diabetes responsive to intravenous but not subcutaneous insulin: effectiveness of aprotinin
9. Insulin degradation in the serum of a patient with apparent insulin resistance
10. Evidence for insulin degradation by muscle and at tissue in an insulin resistant diabetic patient
11. High performance liquid Chromatographie analysis of insulin degradation by rat skeletal muscle insulin protease
12. Pharmaceutical approach to subcutaneous dosage forms of insulin
13. Use of protease inhibitors to protect subcutaneously injected peptide hormones against local degradation
14. Evidence that protease inhibitors reduce the degradation of parathyroid hormone and calcitonin injected subcutaneously
15. Protein digestion in human intestine as reflected in luminal mucosal and plasma amino acid concentrations after meals
16. Insulin administered intranasally as an insulin-bile salt aerosol
17. Powder dosage form of insulin for nasal administration
18. Absorption of insulin delivered to rabbit trachea using aerosol dosage form
19. New mucosal dosage form of insulin
20. Evaluation of permeability enhancement of hydrophilic compounds and macromolecular compounds by bile salts through rabbit corneas in vitro
21. Systemic absorption of ocularly administered enkephalinamide and inulin in the albino rabbit: extent, pathways and vehicle effects
22. The ocular route for systemic insulin delivery in the albino rabbit
23. Enkephalin hydrolysis in homogenates of various absorptive mucosae in the albino rabbit: similarities in rates and involvement of aminopeptidases
24. Mucosal peptide and protein delivery: proteolytic activities in mucosal homogenates
25. Mucosal peptide delivery: susceptibility of insulin and proinsulin to proteolysis and protection from proteolysis by glycocholate
26. Insulin: intestinal absorption as water-in-oil-in-water emulsions
27. Enterai absorption of water-in-oil-in-water insulin emulsions in rabbits
28. Short-term treatment of alloxan-diabetic rats with intrajejunal administration of water-in-oil-in-water insulin emulsions
29. Intrajejunal absorption of liposomally entrapped insulin in normal man
30. Use of liposomes to aid intestinal absorption of entrapped insulin in normal and diabetic dogs
31. Orally administered liposome-entrapped insulin in diabetic animals. A critical assessment
32. The production and evaluation of orally administered insulin nanoparticles
33. New approach for oral administration of insulin with polyalkylcyanoacrylate nanocapsules as drug carrier
34. Targeted enterai delivery of insulin to rats
35. A new approach to the oral administration of insulin and other peptide drugs
36. Nasal delivery of polypeptides. I. Nasal absorption of enkephalins in rats
37. Metabolic and permeation barriers to the ocular absorption of topically applied enkephalins in albino rabbits
38. The transport of an intact oligopeptide across adult mammalian jejunum
39. Subcellular distribution of mucosal proteolytic activities against insulin
40. The absorption of insulin from various regions of the rat intestine
41. Absorption of protein via the intestinal wall: a quantitative model
42. Inhibition of aminopeptidase activity in various mucosal routes of peptide and protein delivery by penetration enhancers
43. The use of α-aminoboronic acid derivatives to stabilize peptide drugs during their intranasal absorption
44. Mechanisms for the enhancement of the nasal absorption of insulin by surfactants
45. Effect of sodium glycocholate and polyoxyethylene-9-lauryl ether on the hydrolysis of varying concentrations of insulin in the nasal homogenates of the albino rabbit
46. Peptide hydrolysis in cytosolic and membrane fractions of the nasal, buccal, and ileal mucosae of the albino rabbit: enkephalins
47. The absorption of tetragastrin from different sites in rats and dogs
48. Vasopressin: a model for the study of effects of additives on the oral and rectal administration of peptide drugs
49. Effect of medium chain glycerides on enterai and rectal absorption of β-lactam and aminoglycoside antibiotics
50. Rectal absorption enhancement of des-enkephalin-γ-endorphin (DEγE) by medium-chain glycerides and EDTA in conscious rats
51. Acylcarnitines drug absorption-enhancing agents in the gastrointestinal tract
52. Absorption enhancing agents for the GI system
53. Unsaturated cyclic ureas as new nontoxic biodegradable transdermal penetration enhancers. I. Synthesis
54. Enzymatic barriers to peptide and protein absorption and the use of penetration enhancers to modify absorption
55. Prevention of molecular self-association by sodium salicylate: effect on insulin and 6-carboxyfluorescein
56. Synergistic effects of penetration enhancers on insulin absorption across the isolated rectal membrane
57. Effect of a diet containing sodium deoxycholate on the intestinal mucosa of the mouse
58. Mechanism of the enhancement of rectal permeability of drugs by nonsteroidal anti-inflammatory drugs
59. Direct effect of bile salts and phospholipids on the physical properties of mucus
60. Enhanced rectal absorption of β-lactam antibiotics in rat by monodesmosides isolated from pericarps of Sapindus mukurossi (enmei-hi)
61. Effect of bile salts on the rectal absorption of sodium ampicillin in rats
62. Calcium binding to intestinal goblet cell mucin
63. Experimental modulation of occluding junctions in a cultured transporting epithelium
64. Effect of extracellular calcium depletion on membrane topography and occluding junctions of mammary epithelial cells in culture
65. A functional assay for proteins involved in establishing an epithelial occluding barrier: identification of unvomorulin-like polypeptide
66. Expression of several adhesive macromolecules (N-CAM, L1, J1, NILE, uvomorulin, laminin, fibronectin and a heparan sulfate proteoglycan) in embryonic, adult and denervated adult skeletal muscle
67. Structure biochemistry and assembly of epithelial tight junctions
68. Cell-adhesion molecule uvomorulin is localized in the intermediate junctions of adult intestinal epithelial cells
69. Zonulae occludentes in junctional complex-enriched fractions from mouse liver: preliminary morphological and biochemical characterizsation
70. Alterations in rat jejunal permeability to a macromolecular tracer during a hyperosmotic load
71. Influence of ionic strength on rectal absorption of gentamicin sulfate in the presence and absence of sodium salicylate
72. Contribution of solvent drag through intercellular junctions to absorption of nutrients by the small intestine of the rat
73. Effects of cytochalasin D on occluding junctions of intestinal absorptive cells: further evidence that the cytoskeleton may influence paracellular permeability and junctional charge selectivity
74. Occluding junction structure-function relationships in a cultured epithelial monolayer
75. 1 renal epithelial tight junctions and transepithelial fluxes
76. Transport of tyrosine and phenylalanine across the rat nasal mucosa
77. Physiological regulation of transepithelial impedance in the intestinal mucosa of rats and hamsters
78. Structural basis for physiological regulation of paracellular pathways in intestinal epithelia
79. Secretion, pain and sneezing induced by the application of capsaicin to the nasal mucosa in man
80. Distinctive patterns of release of neuroendocrine peptides after nasal challenge of allergic subjects with ryegrass antigen
81. Influence of experimental rhinitis on the gonaadotropin response to intranasal administration of buserelin
82. Effect of intranasal histamine on nasal mucosal blood flow and the antidiuretic activity of desmopressin
83. a and acute skin irritation in man
84. Structureactivity relationship of 1-alkyl or 1-alkylazacycloalkanone derivatives as percutaneous penetration enhancers
85. Structure/effect studies of fatty acid isomers as skin penetration enhancers and skin irritants
86. Morphological changes of the small-intestinal mucosa of guinea pig and hamster following incubation in vitro and perfusioon in vivo with unconjugated bile salts
87. Enhanced intestinal absorption of insulin in rats in the presence of sodium 5-methoxysalicylate
88. Effect of sodium 5-methoxysalicylate on macromolecule absorption an dmucosal morphology in a vascularly perfused rat gut preparation in vivo
89. Enhancement of colonie drug absorption by the paracellular permeation route
90. Enhancement of colonie drug absorption by the transcellular permeation route
91. Nasal absorption of insulin: enhancement by hydrophobic bile salts
92. Effect of bile salts on nasal permeability in vitro
93. Effect of surfactants on the nasal absorption of insulin rats
94. Effect of pharmaceutical adjuvants on the rectal permeability of drugs. III. Effect of repeated administration and recovery of the permeability
95. Comparison between the iontophoretic and passive transport of thyrotropin releasing hormone across excised nude mouse skin
96. Blood glucose control in diabetic rats by transdermal iontophoretic delivery of insulin
97. Direct current iontophoretic transdermal delivery of peptide and protein durgs
98. Ultrasound effect of transdermal drug deliver
99. Phonophoresis
100. Nasal absorption of insulin in digs
101. Effects of dose, pH and osmolarity on nasal absorption of secretin in rats. II. Histological aspects of the nasal mucosa in relation to the absorption variation due to the effects of pH and osmolarity
102. Absorption of recombinant methionyl-human growth hormone (met-hGH) from rat nasal mucosa
103. Enhancement of rectal absorption of insulin in polyacrylic acid aqueous gel bases containing long chain fatty acid in rats
104. 1,7] eel calcitonin in rats using polyacrylic acid aqueous gel base
105. Enhancement of nasal absorption of insulin and calcitonin using polyacrylic acid gel
106. Intranasal administration of peptides: nasal deposition, biological response, and absorption of desmopressin
107. Effects of concentration and volume on nasal bioavailability and biological response to desmopressin
108. Bioadhesive microspheres as a potential nasal drug delivery system
109. Degradable starch microspheres as a nasal delivery system for insulin